1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Primary Immune Deficiency (PID) Global Clinical Trials Review, H2, 2015

Primary Immune Deficiency (PID) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Primary Immune Deficiency (PID) Global Clinical Trials Review, H2, 2015" provides an overview of Primary Immune Deficiency (PID) clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Immune Deficiency (PID). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Primary Immune Deficiency (PID) Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Primary Immune Deficiency (PID) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Primary Immune Deficiency (PID) 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Primary Immune Deficiency (PID) Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
CSL Limited 30
Clinical Trial Overview of CSL Limited 30
Octapharma AG 32
Clinical Trial Overview of Octapharma AG 32
Baxter International Inc. 33
Clinical Trial Overview of Baxter International Inc. 33
Bio Products Laboratory Limited 34
Clinical Trial Overview of Bio Products Laboratory Limited 34
Grifols, S.A. 35
Clinical Trial Overview of Grifols, S.A. 35
Kedrion Group S.p.A. 36
Clinical Trial Overview of Kedrion Group S.p.A. 36
Halozyme Therapeutics, Inc. 37
Clinical Trial Overview of Halozyme Therapeutics, Inc. 37
Biotest AG 38
Clinical Trial Overview of Biotest AG 38
Atlantic Research Group 39
Clinical Trial Overview of Atlantic Research Group 39
ADMA Biologics, Inc. 40
Clinical Trial Overview of ADMA Biologics, Inc. 40
Clinical Trial Overview of Top Institutes / Government 41
National Human Genome Research Institute 41
Clinical Trial Overview of National Human Genome Research Institute 41
The National Institute of Allergy and Infectious Diseases 42
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 42
St. Jude Children's Research Hospital, Inc. 43
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 43
University of Pittsburgh 44
Clinical Trial Overview of University of Pittsburgh 44
Ann and Robert H. Lurie Children's Hospital of Chicago 45
Clinical Trial Overview of Ann and Robert H. Lurie Children's Hospital of Chicago 45
Baylor College of Medicine 46
Clinical Trial Overview of Baylor College of Medicine 46
Boston Children's Hospital 47
Clinical Trial Overview of Boston Children's Hospital 47
Columbia University 48
Clinical Trial Overview of Columbia University 48
Dresden University of Technology 49
Clinical Trial Overview of Dresden University of Technology 49
Erasmus MC 50
Clinical Trial Overview of Erasmus MC 50
Five Key Clinical Profiles 51
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 100

List of Tables
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Primary Immune Deficiency (PID) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Primary Immune Deficiency (PID) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Primary Immune Deficiency (PID) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 23
Primary Immune Deficiency (PID) Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Primary Immune Deficiency (PID) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015* 30
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015* 32
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015* 33
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio Products Laboratory Limited, 2015* 34
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015* 35
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kedrion Group S.p.A., 2015* 36
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Halozyme Therapeutics, Inc., 2015* 37
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotest AG, 2015* 38
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Atlantic Research Group, 2015* 39
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by ADMA Biologics, Inc., 2015* 40
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Human Genome Research Institute, 2015* 41
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 42
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2015* 43
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2015* 44
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ann and Robert H. Lurie Children's Hospital of Chicago, 2015* 45
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 46
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2015* 47
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 48
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2015* 49
Primary Immune Deficiency (PID) Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 50

List of Figures
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Primary Immune Deficiency (PID) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Primary Immune Deficiency (PID) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Primary Immune Deficiency (PID) to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Primary Immune Deficiency (PID) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Primary Immune Deficiency (PID) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Primary Immune Deficiency (PID) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 98

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials

Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

Global Genetic Disorders Partnering 2010 to 2016 provides the full collection of Genetic Disorders disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends ...

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of ...

Alpha-Mannosidosis Global Clinical Trials Review, H2, 2016

Alpha-Mannosidosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Alpha-Mannosidosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Alpha-Mannosidosis Global Clinical Trials Review, H2, 2016" provides an overview of Alpha-Mannosidosis ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.